Contribution of HIV/AIDS to global blindness

International Ophthalmology Clinics

Volumn 47, Issue 3, 2007, Pages 27-43

  Shukla, Dhananjay ^a   Rathinam, Sivakumar R ^a   Cunningham Jr , Emmett T ^b  

^a ARAVIND EYE HOSPITAL   (India)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CIDOFOVIR; FANSIDAR; PROTEINASE INHIBITOR; RIFABUTIN; SULFANILAMIDE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AFRICA; BLINDNESS; CRYPTOCOCCAL MENINGITIS; CRYPTOCOCCOSIS; CYTOMEGALOVIRUS INFECTION; DRY EYE; EASTERN EUROPE; GEOGRAPHIC DISTRIBUTION; HERPES ZOSTER OPHTHALMICUS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; IRIDOCYCLITIS; KAPOSI SARCOMA; MOLLUSCUM CONTAGIOSUM; MORBIDITY; MYCOBACTERIOSIS; NEUROOPHTHALMOLOGY; NONHODGKIN LYMPHOMA; NORTH AMERICA; OCULAR HISTOPLASMOSIS; PREVALENCE; PRIORITY JOURNAL; RETINA MACULOPATHY; RETINITIS; REVIEW; SOUTH ASIA; SOUTHEAST ASIA; STEVENS JOHNSON SYNDROME; SYPHILIS; TOXOPLASMOSIS; TUBERCULOSIS; WESTERN EUROPE;

BLINDNESS; HIV INFECTIONS; HUMANS; PREVALENCE; WORLD HEALTH;

EID: 34547617875     PISSN: 00208167     EISSN: None     Source Type: Journal    
DOI: 10.1097/IIO.0b013e318074e60c     Document Type: Review

References (62)

1. Gao F, Bailes E, Robertson DL, et al. Origin of HIV-1 in the chimpanzee Pan troglodytes troglodytes. Nature. 1999;397:436-441.
2. Cunningham ET Jr. HIV/AIDS and global blindness. In: Van Newkirk M, Alfonso EC, Chuang EL, et al, eds. International Ophthalmology. San Francisco: American Academy of Ophthalmology; 2004:223-234.
3. Centers for Disease Control and Prevention (CDC). The Global HIV/AIDS Pandemic, 2006. MMWR. 2006;55:841-844.
4. Holland GN, Gottlieb MS, Yee RD, et al. Ocular disorders associated with a new severe acquired cellular immunodeficiency syndrome. Am J Ophthalmol. 1982;93:393-402.
5. Barre-Sinoussi F, Chermann JC, Rey F, et al. Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). Science. 1983;220:868-871.
6. Gallo RC, Salahuddin SZ, Popovic M, et al. Frequent detection and isolation of cytopathic retroviruses (HTLV-III) from patients with AIDS and at risk for AIDS. Science. 1984;224:500-503.
7. Joint United Nations Programme on HIV/AIDS (UNAIDS). 2006 report on the global AIDS epidemic: epidemic update Dec. 2006. Geneva, Switzerland: UNAIDS, 2006. Available at: http://www.unaids.org/en/hiv_data/2006globalreport/default. asp. Accessed December 12, 2006.
8. Mahomva A, Greby S, Dube S, et al. HIV prevalence and trends from data in Zimbabwe, 1997-2004. Sex Transm Infect. 2006;82(suppl 1):i42-i47.
9. India in spotlight. Lancet. 2006;367:1876.
10. Steinbrook R. HIV in India-a complex epidemic. N Eng J Med. 2007;356:1089-1093.
11. Ruxrungtham K, Brown T, Phanuphak P. HIV/AIDS in Asia. Lancet. 2004;364:69-82.
12. EuroHIV. HIV/AIDS surveillance in Europe: end-year report 2005, No. 73. Saint-Maurice, Institut de Veille Sanitaire.
13. Okie S. Fighting HIV-lessons from Brazil. N Eng J Med. 2006;354:1977-1981.
14. Centers for Disease Control and Prevention (CDC). Trends in HIV/AIDS diagnoses-33 states, 2001-2004. MMWR. 2005;54:1149-1153.
15. Centers for Disease Control and Prevention (CDC). Racial/ethnic disparities in diagnoses of HIV/AIDS-33 states, 2001-2004. MMWR. 2006;55:121-125.
16. Cunningham ET Jr, Margolis TP. Ocular manifestations of HIV infection. N Engl J Med. 1998;339:236-244.
17. Kestelyn PG, Cunningham ET Jr. HIV/AIDS and blindness. Bull World Health Organ. 2001;79:208-213.
18. Vrabec TR. Posterior segment manifestations of HIV/AIDS. Surv Ophthalmol. 2004;49:131-157.
19. Ng WT, Versace P. Ocular association of HIV infection in the era of highly active antiretroviral therapy and the global perspective. Clin Exp Ophthalmol. 2005;33:317-329.
20. Cunningham ET Jr, Belfort R Jr. HIV/AIDS and the Eye: A Global Perspective. San Francisco: American Academy of Ophthalmology; 2002.
21. Kempen JH, Jabs DA. Ocular complications of human immunodeficiency virus infection. In: Johnson GJ, Minassian DC, Weale R, et al, eds. The Epidemiology of Eye Diseases. 2nd ed. London: Arnold; 2003:318-340.
22. Beare NAV, Kublin JG, Lewis DK, et al. Ocular disease in patients with tuberculosis and HIV presenting with fever in Africa. Br J Ophthalmol. 2002;86:1076-1079.
23. Biswas J, Madhavan HN, George AE, et al. Ocular lesions associated with HIV infection in India: a series of 100 consecutive patients evaluated at a referral center. Am J Ophthalmol. 2000;129:9-15.
24. Muccioli C, Belfort R Jr, Lottenberg C, et al. Achados oftalmologicos em AIDS: avaliacao de 445 casos atendidos em um ano [Ophthalmological manifestations in AIDS: evaluation of 445 patients in one year]. Rev Assos Med Brasil. 1994;40:155-158.
25. Raina J, Bainbridge JW, Shah SM. Decreased visual acuity in patients with cytomegalovirus retinitis and AIDS. Eye. 2000;14:8-12.
26. Pecorella I, Ciardi A, Credendino A, et al. Ocular, cerebral and systemic interrelationships of cytomegalovirus infection in a post-mortem study of AIDS patients. Eye. 1999;13:781-785.
27. Kempen JH, Jabs DA, Wilson LA, et al. Risk of vision loss in patients with cytomegalovirus retinitis and the acquired immunodeficiency syndrome. Arch Ophthalmol. 2003;121:466-476.
28. Kempen JH, Jabs DA, Wilson LA, et al. Mortality risk for patients with cytomegalovirus retinitis and acquired immune deficiency syndrome. Clin Infect Dis. 2003;37: 1365-1373.
29. Jabs DA. Ocular manifestations of HIV infection. Trans Am Ophthalmol Soc. 1995;93:623-683.
30. Van de Perre P, Bakkers E, Batungwanayo J, et al. Herpes zoster in African patients: an early manifestation of HIV infection. Scand J Infect Dis. 1988;20:277-282.
31. Edhonu-Elyetu Y. Significance of herpes zoster in HIV/AIDS in Kweneng district, Botswana. East Afr Med J. 1998;75:379-381.
32. Amirali W, Moshiro C, Ramaiya K. Assessment of clinical case-definition for HIV/AIDS in Tanzania. East Afr Med J. 2004;81:226-229.
33. Kestelyn P, Van de Perre P, Rouvroy D, et al. A prospective study of the ophthalmologic findings in the acquired immune deficiency syndrome in Africa. Am J Ophthalmol. 1985;100:230-238.
34. Shalaby IA, Dunn JP, Semba RD, et al. Syphilitic uveitis in human immunodeficiency virus-infected patients. Arch Ophthalmol. 1997;115:469-473.
35. Lynn WA, Lightman S. Syphilis and HIV: a dangerous combination. Lancet Infect Dis. 2004;4:456-466.
36. Havlir DV, Barnes PF. Tuberculosis in patients with human immunodeficiency virus infection. N Engl J Med. 1999;5:367-373.
37. Steinbrook R. Tuberculosis and HIV in India. N Engl J Med. 2007;356:1198-1199.
38. HIV-related opportunistic diseases: UNAIDS Technical Update. October 1998. Available at: data.unaids.org/Publications/IRC-pub05/opportu_en.pdf. Accessed December 15, 2006.
39. Satishchandra P, Nalini A, Gourie-Devi M, et al. Profile of neurologic disorders associated with HIV/AIDS from Bangalore, south India (1989-96). Indian J Med Res. 2000;111:14-23.
40. Mielke J. Neurological complications of human immunodeficiency virus infection in Zimbabwe-2005. J Neurovirol. 2005;11(suppl 3):23-25.
41. Kestelyn PG, Taelman H, Bogaerts J, et al. Ophthalmic manifestations of infections with Cryptococcus neoformans in patients with the acquired immunodeficiency syndrome. Am J Ophthalmol. 1993;116:721-727.
42. Cunningham ET Jr. Uveitis in HIV positive patients. Br J Ophthalmol. 2000;84:233-237.
43. Nguyen QD, Kempen JH, Bolton SG, et al. Immune recovery uveitis in patients with AIDS and cytomegalovirus retinitis after highly active antiretroviral therapy. Am J Ophthalmol. 2000;129:634-639.
44. Karavellas MP, Plummer DJ, Macdonald JC, et al. Incidence of immune recovery vitritis in cytomegalovirus retinitis patients following institution of successful highly active antiretroviral therapy. J Infect Dis. 1999;179:697-700.
45. Song MK, Azen SP, Buley A, et al. Effect of anti-cytomegalovirus therapy on the incidence of immune recovery uveitis in AIDS patients with healed cytomegalovirus retinitis. Am J Ophthalmol. 2003;136:696-702.
46. Coster DJ. Stevens-Johnson syndrome. Dev Ophthalmol. 1997;28:24-31.
47. Kestelyn PG, Lewallen S. Ocular problems with HIV infection and AIDS in Africa. Community Eye Health. 1995;8:20-23.
48. Dennehy PJ, Warman R, Flynn JT, et al. Ocular manifestations in pediatric patients with acquired immunodeficiency syndrome. Arch Ophthalmol. 1989;107:978-982.
49. Moraes HV Jr. Ocular manifestations of HIV/AIDS. Curr Opin Ophthalmol. 2002;13:397-403.
50. Biswas J, Kumar AA, George AE, et al. Ocular and systemic lesions in children with HIV. Indian J Pediatr. 2000;67:721-724.
51. HIV/AIDS: not one epidemic but many. Lancet. 2004;364:1-2.
52. Branson BM, Handsfield HH, Lampe MA, et al. Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings. MMWR. 2006;55:1-17.
53. Marks G, Crepaz N, Janssen R. Estimating sexual transmission of HIV from persons aware and unaware that they are infected with the virus in the USA. AIDS. 2006;20:1447-1450.
54. Gostin LO. HIV Screening in health care settings: public health and civil liberties in conflict? JAMA. 2006;296:2023-2025.
55. Bunnell R, Mermin J, De Cock KM. HIV Prevention for a threatened continent: implementing positive prevention in Africa. JAMA. 2006;296:855-858.
56. Allen S, Tice J, van de Perre P, et al. Effect of serotesting with counselling on condom use and seroconversion among HIV discordant couples in Africa. BMJ. 1992;304:1605-1609.
57. Liu AY, Grant RM, Buchbinder SP. Preexposure prophylaxis for HIV: unproven promise and potential pitfalls. JAMA. 2006;296:863-865.
58. Kuehn BM. Routine male circumcision could prevent millions of HIV infections in Africa. JAMA. 2006;296:755.
59. Williams BG, Lloyd-Smith JO, Gouws E, et al. The potential impact of male circumcision on HIV in Sub-Saharan Africa. PLoS Med. 2006;3:e262. Available from: PLOS medicine. Accessed December 20, 2006.
60. Bozzette SA, Joyce G, McCaffrey DF, et al. Expenditures for the care of HIV-infected patients in the era of highly active antiretroviral therapy. N Engl J Med. 2001;344:817-823.
61. Nagelkerke NJ, Jha P, de Vlas SJ, et al. Modelling HIV/AIDS epidemics in Botswana and India: impact of interventions to prevent transmission. Bull World Health Organ. 2002;80:89-96.
62. Scaling up antiretroviral therapy in resource-limited settings: treatment guidelines for a public health approach-2003 revision. Geneva: World Health Organization, 2003. Available at: http://www.who.int/3by5/publications/ documents/arv_guidelines/en/. Accessed December 29, 2006.